Abstract：【Objective】To investigate the relationship between histone deacetylase 6 (HDAC6) protein level in tissue samples and clinicopathological features of patients with endometrial cancer. 【Methods】 A total of 90 patients with endometrial cancer who underwent surgery in our hospital from March 2018 to March 2020 was selected as the research objects. The specimens of cancer tissues and adjacent normal tissues of all patients after surgery were taken, and the expression of HDAC6 protein in tissue samples was measured by immunohistochemical staining. The positive rate of HDAC6 protein in cancer tissues and adjacent normal tissues of all patients and the expression of HDAC6 protein in cancer tissues of endometrial cancer patients with different clinicopathological features were compared. 【Results】The positive rate of HDAC6 protein in endometrial carcinoma was significantly higher than that in adjacent tissues (P<0.05). There was no significant difference in the positive rate of HDAC6 protein in endometrial cancer patients with different age, pathological classification, histological grade and cervical involvement (P>0.05); The positive rate of HDAC6 protein in patients with stage Ⅲ~Ⅳ was significantly higher than that in patients with stageⅠ~Ⅱ(P<0.05); The positive rate of HDAC6 protein in patients with lymph node metastasis was significantly higher than that in patients without lymph node metastasis (P<0.05); The positive rate of HDAC6 protein in patients with myometrial infiltration ≥ 1/2 was significantly higher than that in patients with myometrial infiltration < 1/2 (P<0.05). 【Conclusion】 The expression of HDAC6 protein is up-regulated in endometrial carcinoma, and its expression level is closely related to FIGO stage, lymph node metastasis and myometrial invasion depth.
宋燕, 马成斌, 李冰, 吴慧恒, 吴琼蔚. 组织标本中组蛋白去乙酰化酶6蛋白水平与子宫内膜癌患者临床病理特征的关系[J]. 医学临床研究, 2021, 38(12): 1780-1783.
SONG Yan, MA Cheng-bin, LI Bing, et al. Relationship between Histone Deacetylase 6 Protein Level in Tissue Samples and Clinicopathological Features of Patients with Endometrial Cancer. JOURNAL OF CLINICAL RESEARCH, 2021, 38(12): 1780-1783.
2021, Vol. 38 
